
Lung Cancer Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.
Featured
In the second installment of this roundtable discussion, experts sat down with Oncology Learning Network to discuss use of liquid biopsies to detect treatment resistance in lung cancer, areas for…
View MoreClaire Verschraegen, MD, comments on a phase 2 study examining the use of chemotherapy with durvalumab in patients with pleural mesothelioma.
View MoreDr Bauml discusses how he and his lung cancer patients have adapted during this unprecedented time.
View MoreHelen Ross, MD, discusses the role of antiangiogenics over time in treating NSCLC.
View MoreShirish Gadgeel, MBBS, discusses updated findings from the KEYNOTE-189 clinical trial.
View MoreKristin Higgins, MD, Winship Cancer Institute, shares how the treatment of patients with lung cancer has been impacted by the COVID-19 pandemic.
View MoreHelen Ross, MD, discusses the need to screen patients with NSCLC for driver mutations via NGS at diagnosis and after progression to help select first-, second-, and third-line targeted therapies.
View MoreJoshua Bauml, MD, shares first-hand insight on the management of lung cancer during the COVID-19 pandemic.
View MoreJames L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
View More